Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Participants suffering from mild to moderate acute low back pain~* Low back pain (lumbar back pain) is defined as pain in the back from the level of the lowest rib down to the gluteal fold~* Acute episode is defined as acute pain with less than 1 month duration~* With intensity less than or equal to 6 on 0-10 Numerical Rating Scale (NRS)~Exclusion Criteria:~* Participants suffering from any neurological pathology which could be responsible of the pain~* Participants suffering from leg pain irradiation~* Participants suffering from chronic lumbar pain of any etiology~* Participants with chronic arthrosis and neurological symptoms~* Participants experiencing recent significant trauma (i.e., injury related to a fall from a height or motor vehicle crash, or from a minor fall or heavy lifting in a participants with osteoporosis or possible osteoporosis)~* Participants with major or progressive motor or sensory deficit, new-onset bowel or bladder incontinence or urinary retention, loss of anal sphincter tone, saddle anesthesia, history of cancer metastatic to bone, and suspected spinal infection~* Participants clinically diagnosed with anxiety and/or depression~* Participants using any medication for their pain within the last 48 hours within enrollment into the study~* Participants taking any systemic medication for their pain within the last 24 hours (48 hours for diclofenac or corticosteroids)~* Participants currently using recreational or illicit drugs or with a recent history of drug or alcohol abuse or dependence~* Participants with any other medical condition that would interfere with efficacy and safety assessments based on investigator's judgment~* Participants having received non-pharmaceutical lower back pain treatment (physiotherapy, heat treatment or massage) within 12 hours prior to enrollment~* Participants having received spinal injection back pain treatment within 6 months prior to enrollment~* Participants having received surgery due to back pain or rehabilitation due to back pain in the last 12 months~* Participants with a known sensitivity to paracetamol~* Participants with known cutaneous hypersensitivity to plaster~* Participants participating in another clinical study within the past 30 days~* Participants who are pregnant or breastfeeding; contraception is mandatory~* Participants having damaged, non-intact, or scarred skin in or near the point of patch application~* Participants having a known skin sensitivity~* Participants having impaired blood circulation~The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- ITP FIRTECH (Type: EXPERIMENTAL): The ITP FIRTECH patch was applied on the lower back region of the body on Day 1 and intended to be worn for 5 Days (Day 5).
- No Patch Control Arm (Type: NO_INTERVENTION): No patch application.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete